Examples of clinical effects associated with air pollution*.
| Respiratory | Cardiovascular | Neurological and psychiatric conditions |
|---|---|---|
| Increased respiratory mortalityIncreased incidence of malignant tumors of the respiratory tractIncreased incidence, prevalence, or frequency of exacerbations in chronic lung diseases: asthma, COPD, and cystic fibrosisIncreased incidence or severity of upper and lower respiratory tract infectionsIncreased respiratory symptoms affecting quality of life: cough, phlegm, wheezing, dyspnoea and nasal secretionIncreased incidence of premature births, low birth weight, or growth limitation leading to adverse respiratory outcomesReduced growth of lung function in childrenTransient reductions (hours) in lung function associated with symptoms in healthy individualsTransient reductions (hours) in symptom-free lung function in particularly sensitive individuals (e.g., children with severe asthma)Persistent or chronic (weeks, months, or years) decreases in lung function | Mortality from cardiovascular diseasesMyocardial infarctionStrokeIncreased blood pressureArrhythmiasHospital admissions for congestive heart failure | Alzheimer’s disease and other dementiasParkinson’s diseaseReduced cognitive function in adultsNeurodevelopmental delay in ChildrenDepressionAnxiety disorders |
*: Modified from [20]. COPD: chronic obstructive pulmonary disease.
Supplementary materials for this article are available at: https://www.explorationpub.com/uploads/Article/file/1009135_sup_1.pdf.
This document represents a virtuous example of national scientific collaboration, born from the joint commitment of experts of nine scientific societies, which have shared skills, data and strategic vision to address one of the most urgent challenges of contemporary public health.
We thank the Presidents of the nine Scientific Societies that have joined the initiative with promptness and conviction, recognizing its urgency and strategic value: Prof. Vincenzo Patella, President of the Italian Society of Allergology, Asthma and Clinical Immunology (SIAAIC); Prof. Lorenzo Richiardi, President of the Italian Association of Epidemiology (AIE); Prof. Francesco Murzilli, President of the Association of Italian Territorial and Hospital Allergists and Immunologists (AAIITO); Prof. Raffaele Scala, President of the Italian Association of Hospital Pulmonologists (AIPO); Prof. Gian Luigi Marseglia, President of the Italian Society of Paediatric Allergology and Immunology (SIAIP); Prof. Augusto Arsieni, President of the Italian Society of Aerobiology, Medicine and Environment (SIAMA); Prof. Maurizio Coggiola, President of the Italian Society of Occupational Medicine (SIML); Prof. Stefania La Grutta, President of the Italian Society for Childhood Respiratory Diseases (SIMRI); Prof. Paola Rogliani, President of the Italian Society of Pneumology (SIP).
The experts of the inter-society Task Force are: Manuela De Sario, Silvia Maritano (AIE); Paolo Borrelli, Gabriele Cortellini (AAIITO); Carlo Barbetta, Francesco Menzella (AIPO); Manlio Milanese, Giovanni Viegi (SIAAIC); Cristiana Indolfi, Giovanni Traina (SIAIP); Augusto Arsieni, Emma Tedeschini (SIAMA); Massimo Corradi, Nicola Murgia (SIML); Giuliana Ferrante, Raffaella Nenna (SIMRI); Laura Carrozzi, Sara Maio (SIP).
GV: Conceptualization, Writing—original draft, Writing—review & editing, Supervision. SM: Writing—original draft, Writing—review & editing. AA: Writing—original draft, Writing—review & editing. CB: Writing—original draft, Writing—review & editing. PB: Writing—original draft, Writing—review & editing. LC: Writing—original draft, Writing—review & editing. MC: Writing—original draft, Writing—review & editing. GC: Writing—original draft, Writing—review & editing. MDS: Writing—original draft, Writing—review & editing. GF: Writing—original draft, Writing—review & editing. CI: Writing—original draft, Writing—review & editing. SM: Writing—original draft, Writing—review & editing. FM: Writing—original draft, Writing—review & editing. MM: Writing—original draft, Writing—review & editing. NM: Writing—original draft, Writing—review & editing. RN: Writing—original draft, Writing—review & editing. ET: Writing—original draft, Writing—review & editing. GT: Writing—original draft, Writing—review & editing. VP: Supervision. All authors read and approved the submitted version.
Vincenzo Patella, who is the Editorial Board Member and Guest Editor of Exploration of Asthma & Allergy; Manlio Milanese, who is the Guest Editor of Exploration of Asthma & Allergy. The remaining authors declare that they have no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2026.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.